Del 98 - Advances in Protein Chemistry and Structural Biology

Protein and Peptide Nanoparticles for Drug Delivery

Inbunden, Engelska, 2015

2 439 kr

Beställningsvara. Skickas inom 7-10 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

Published continuously since 1944, the Advances in Protein Chemistry and Structural Biology series has been the essential resource for protein chemists. Each volume brings forth new information about protocols and analysis of proteins. Each thematically organized volume is guest edited by leading experts in a broad range of protein-related topics.

Describes advances in application of powerful techniques in a wide bioscience area
Chapters are written by authorities in their field
Targeted to a wide audience of researchers, specialists, and students
The information provided in the volume is well supported by a number of high quality illustrations, figures, and tables

Produktinformation

Utgivningsdatum2015-03-25
Mått152 x 229 x undefined mm
Vikt750 g
FormatInbunden
SpråkEngelska
SerieAdvances in Protein Chemistry and Structural Biology
Antal sidor396
FörlagElsevier Science
ISBN9780128028285

Tillhör följande kategorier

Farmakologi inom Medicin

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.

Protein- and Peptide-Drug Conjugates: An Emerging Drug Delivery TechnologyImran Vhora, Sushilkumar Patil, Priyanka Bhatt and Ambikanandan MisraModifications of Natural Peptides for Nanoparticle and Drug DesignAndrew P. Jallouk, Rohun U. Palekar, Hua Pan, Paul H. Schlesinger and Samuel A. WicklineHybrid Protein–Synthetic Polymer Nanoparticles for Drug DeliveryNeli S. Koseva1, Joanna Rydz, Ekaterina V. Stoyanova and Violeta A. Mitova Efficient Delivery of Therapeutic Agents by Using Targeted Albumin NanoparticlesHasan Kouchakzadeh, Maryam Sadat Safavi and Seyed Abbas ShojaosadatiVasoactive Intestinal Peptide (VIP) Nanoparticles for Diagnostics and for Controlled and Targeted Drug DeliveryRebecca Klippstein and David PozoImplications of Protein- and Peptide-Based Nanoparticles as Potential Vehicles for Anticancer DrugsAhmed. O. Elzoghby, Mayada. M. Elgohary and Nayra M. KamelPolysaccharide Nanoparticles for Protein and Peptide Delivery: Exploring Less-Known MaterialsMarlise Araújo dos Santos and Ana GrenhaBioconjugation of Silk Fibroin Nanoparticles with Enzyme and Peptide and Their Characterization Fei Wang and Yu-Qing ZhangFood-Grade Protein-Based Nanoparticles and Microparticles for Bioactive Delivery: Fabrication, Characterization, and UtilizationGabriel Davidov-Pardo, Iris J. Joye and David Julian McClements